DeBock, F
Alpha2-adrenoreceptor activation inhibits LTP and LTD in the basolateral amygdala: involvement of Gi/o-protein-mediated modulation of Ca2+-channels and inwardly rectifying K+-channels in LTD. [electronic resource]
- The European journal of neuroscience Apr 2003
- 1411-24 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
ISSN: 0953-816X
Standard No.: 10.1046/j.1460-9568.2003.02544.x doi
Subjects--Topical Terms: 3',5'-Cyclic-AMP Phosphodiesterases--pharmacology Adenylyl Cyclase Inhibitors Adrenergic alpha-Agonists--pharmacology Adrenergic alpha-Antagonists--pharmacology Amygdala--physiology Animals Barium--pharmacology Cadmium--pharmacology Calcium Channel Blockers--pharmacology Calcium Channels--metabolism Clonidine--pharmacology Colforsin--pharmacology Cyclic Nucleotide Phosphodiesterases, Type 4 Electric Stimulation Enzyme Inhibitors--pharmacology Excitatory Postsynaptic Potentials--drug effects Heterotrimeric GTP-Binding Proteins--classification Imines--pharmacology In Vitro Techniques Isoquinolines--pharmacology Long-Term Potentiation--physiology Long-Term Synaptic Depression--physiology Membrane Potentials--drug effects Mice Norepinephrine--pharmacology Patch-Clamp Techniques--methods Pertussis Toxin--pharmacology Piperazines--pharmacology Potassium Channel Blockers--pharmacology Potassium Channels, Inwardly Rectifying--metabolism Pyridines--pharmacology Receptors, Adrenergic, alpha-2--metabolism Serotonin Antagonists--pharmacology Sulfonamides Yohimbine--pharmacology omega-Agatoxin IVA--pharmacology omega-Conotoxins--pharmacology